LIPO

Lipella Pharmaceuticals Inc.

LIPO·53630L100·UQ·Common Stock·Healthcare - Biotechnology

LIPO (Lipella Pharmaceuticals Inc.) is held by 0 institutional investors as of Q2 2025. Net institutional sentiment: Bearish.

0
Holders
$0
Total Value
0% (2)
Consensus
0 buying - 2 selling
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold LIPO.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
MAI Capital ManagementMAI Capital Management
Exited
0(-100.0%)$3140.0%-71.15%
0
BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/
Exited
0(-100.0%)$180.0%-71.15%
0
LIPOLIPOLipella Pharmaceuticals Inc.

Continue exploring

Smart money flow
Track where institutional capital is flowing
Discover new institutional entries
Fresh positions initiated this quarter
Check sector trends
Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYLLYELI LILLY & CO
403 holders · $856.6B
UNHUNHUNITEDHEALTH GROUP INC
403 holders · $286.8B
TMOTMOTHERMO FISHER SCIENTIFIC INC
388 holders · $148B
JNJJNJJOHNSON & JOHNSON
385 holders · $405.5B
DHRDHRDANAHER CORP
384 holders · $95B
ISRGISRGINTUITIVE SURGICAL INC
381 holders · $105.8B
MRKMRKMERCK & CO. INC.
378 holders · $226B
BSXBSXBOSTON SCIENTIFIC CORP
375 holders · $51.2B
ABBVABBVABBVIE INC
373 holders · $296.3B
ABTABTABBOTT LABORATORIES
371 holders · $110.7B
High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used